Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Study of Inhaled ARO-RAGE in Allergen-induced Mild AsthmaNCT07241546Arrowhead PharmaceuticalsPhase 2Recruiting2027-12Estimated
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)NCT07246590VRCAPhase 3Recruiting2027-06Estimated
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)NCT07252232RVMDPhase 3Recruiting2029-05-10Estimated
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaNCT07256392Celldex TherapeuticsPhase 3Enrolling by invitation2028-09Estimated
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaNCT07259317Corcept TherapeuticsPhase 2Recruiting2027-09Estimated
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaNCT07265947TYRAPhase 2Recruiting2030-10Estimated
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)NCT07266402Celldex TherapeuticsPhase 3Recruiting2028-06Estimated
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)NCT07268638Akebia TherapeuticsPhase 2Recruiting2027-06Estimated
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesNCT07271667CRISPhase 2Recruiting2027-11Estimated
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)NCT07276724Generate BiomedicinesPhase 3Recruiting2028-12Estimated
Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's DiseaseNCT07280299GANXPhase 2Not yet recruiting2028-06-30Estimated
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaNCT07282587Jazz PharmaceuticalsPhase 2Recruiting2028-12-15Estimated
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisNCT07284459Contineum TherapeuticsPhase 2Recruiting2028-05Estimated
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49NCT07284654PCVXPhase 3Active not recruiting2027-01Estimated
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant ResponseNCT07284667ACADPhase 2Recruiting2027-08Estimated
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaNCT07284758CCCCPhase 2Recruiting2030-03Estimated
A Study of Buntanetap in Participants With PDNCT07284784ANVSPhase 2, Phase 3Recruiting2029-09Estimated
Clinical Trial of Vormatrigine in Adult Patients With EpilepsyNCT07287163Praxis Precision MedicinesPhase 3Enrolling by invitation2028-05-31Estimated
Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsNCT07287189MSLEPhase 2Recruiting2027-03-31Estimated
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced MelanomaNCT07288203IOVAPhase 2Active not recruiting2032-12Estimated
Transition to KPL-387 Monotherapy Dosing & Administration StudyNCT07288216KNSAPhase 2Recruiting2027-12-31Estimated
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2NCT07288398TENXPhase 3Recruiting2028-06-30Estimated
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisNCT07290569ORKAPhase 2Active not recruiting2027-06Estimated
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)NCT07298330MIRMPhase 3Active not recruiting2026-08Estimated
Study of VYD2311 for the Prevention of COVID-19NCT07298434IVVDPhase 3Active not recruiting2026-08Estimated
Donidalorsen Treatment in Children With Hereditary AngioedemaNCT07298447IONSPhase 3Recruiting2029-06Estimated
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019Zenas BioPharma (USA), LLCPhase 3Recruiting2030-06Estimated
A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907Definium Therapeutics US, Inc.Phase 2Recruiting2027-08Estimated
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaNCT07323654KYMRPhase 2Recruiting2027-12Estimated
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIINCT07326566BDTXPhase 2Recruiting2028-11Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.